Jasmin Moshfegh (@jasminmoshfegh.bsky.social)

🚨Do GLP-1s “pay for themselves”? We study real-world impacts at scale. An estimated 1 in 8 Americans have tried GLP-1s. But beyond clinical trials, we know surprisingly little about their real-world effects. Paper: nber.org/papers/w34667 (w/ @jasminmoshfegh.bsky.social & Sam Bock) 🧵1/10

loading . . .

Weighing the Impacts of GLP-1s: Quasi-Experimental Evidence From Provider Adoption Founded in 1920, the NBER is a private, non-profit, non-partisan organization dedicated to conducting economic research and to disseminating research findings among academics, public policy makers, an... http://nber.org/papers/w34667